Lp(a)-enriched plasma undergoes increasingly rapid oxidation at elevated levels, with oxidation inhibited by eicosapentaenoic acid (EPA), irrespective of enrichment level. These are the findings from a study investigating lipid oxidation rates in increasingly enriched Lp(a) plasma and the potential antioxidant activity of EPA.
Educational Partners and Supporters
AstraZeneca has provided a sponsorship grant towards this independent programme.
(Founding Partner)
Novartis has provided with arm’s length sponsorship towards the set-up of the Lp(a) Forum. The content was developed independently by the Forum.
